Generation Bio Co.
GBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $71 | $106 | $228 | $399 |
| - Cash | $76 | $66 | $93 | $375 |
| + Debt | $94 | $98 | $82 | $81 |
| Enterprise Value | $88 | $138 | $217 | $104 |
| Revenue | $20 | $6 | $0 | $0 |
| % Growth | 236.9% | – | – | – |
| Gross Profit | $20 | $6 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$74 | -$133 | -$136 | -$115 |
| % Margin | -373.3% | -2,257.8% | – | – |
| Net Income | -$132 | -$127 | -$137 | -$119 |
| % Margin | -661.9% | -2,144.5% | – | – |
| EPS Diluted | -19.76 | -19.63 | -23.51 | -21.17 |
| % Growth | -0.7% | 16.5% | -11.1% | – |
| Operating Cash Flow | -$89 | -$53 | -$102 | -$92 |
| Capital Expenditures | -$2 | -$7 | -$9 | -$6 |
| Free Cash Flow | -$91 | -$60 | -$111 | -$98 |